Literature DB >> 1928597

Effect of 5-fluorouracil in cholesteatoma development in an animal model.

C G Wright1, L L Bird, W L Meyerhoff.   

Abstract

This investigation was designed to evaluate the effects of the antimetabolite 5-fluorouracil (5-FU) on cholesteatoma formation in a chinchilla model. The animals received middle ear applications of propylene glycol according to a procedure previously shown to produce cholesteatomas in 60% to 70% of animals. A 5% solution of 5-FU was then applied to the lateral surface of the tympanic membrane (TM) and, after 1 month, temporal bones were taken for histologic study. No macroscopically visible cholesteatomas were present in any of the 16 temporal bones included in the study. However, microscopic invasion of epidermis to the medial side of the TM was observed in four specimens; perforations were present in three of these. Although there was considerable variability in the response to 5-FU application, the majority of specimens showed little or no proliferation of connective tissue in the lamina propria of the TM. In the four specimens in which epidermis reached the medial side of the TM, it did so either by migration through microscopic breaks in the fibrous layer or via TM perforations. Thus, 5-FU did not completely inhibit migration of epidermis into the middle ear. However, the results of this study indicate that it does tend to reduce the proliferation of TM epidermis and connective tissue, thereby reducing the likelihood of cholesteatoma formation in the experimental model.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928597     DOI: 10.1016/0196-0709(91)90142-3

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  6 in total

1.  Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity.

Authors:  Tomomi Yamamoto-Fukuda; Mariko Terakado; Yoshitaka Hishikawa; Takehiko Koji; Haruo Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-02       Impact factor: 2.503

Review 2.  Animal models of middle ear cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Haruo Takahashi; Takehiko Koji
Journal:  J Biomed Biotechnol       Date:  2011-04-06

3.  Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism.

Authors:  Matthias Schürmann; Felix Oppel; Senyao Shao; Verena Volland-Thurn; Christian Kaltschmidt; Barbara Kaltschmidt; Lars-Uwe Scholtz; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2021-02-24       Impact factor: 5.712

4.  Inhibitory effect of mesna and 5-fluorouracil on propylene glycol-induced cholesteatoma in rats.

Authors:  Numan Kokten; Ozan Tuysuz; Tulay Zenginkinet; Fatih Mehmet Hanege; Mahmut Tayyar Kalcioglu
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-10       Impact factor: 2.124

Review 5.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

6.  Effect of trans-retinoic acid in the inhibition of cholesteatoma in guinea pigs.

Authors:  Marcos Luiz Antunes; Yotaka Fukuda; Norma de Oliveira Penido; Rimarcs Ferreira
Journal:  Braz J Otorhinolaryngol       Date:  2008 Jan-Feb
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.